The top of executive of Novo Nordisk told a Senate panel Tuesday it was a "difficult choice" to discontinue the long-acting ...

For 13 years, Molly King has depended on an insulin drug to manage her Type 1 diabetes. On Dec. 31, that drug will be wiped ...

Concerns are rising as Novo Nordisk's $16.5 billion bid to acquire Catalent faces scrutiny from the FTC. Critics argue the ...

Healthcare is always a hot-button topic discussed during election years. This election cycle is no different, especially for ...

Multiple senators questioned Jorgensen over Novo Nordisk’s recent announcement that it would stop manufacturing a specific ...

Lars Fruergaard Jørgensen, Novo Nordisk's CEO, says his company is working to expand manufacturing to meet the supply shortages.

Healthcare is always a hot button topic discussed during election years. This election cycle is no different, especially for ...

Read about how a nurse working at a care home was referred to the Nursing and Midwifery Council’s fitness-to-practise panel ...

The CEO of Novo Nordisk wouldn’t commit to lowering the prices of Ozempic and Wegovy during a Senate hearing Tuesday, despite ...